Allianz Asset Management GmbH Invests $638,000 in USANA Health Sciences, Inc. $USNA

Allianz Asset Management GmbH acquired a new position in USANA Health Sciences, Inc. (NYSE:USNA) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 20,889 shares of the company’s stock, valued at approximately $638,000. Allianz Asset Management GmbH owned about 0.11% of USANA Health Sciences as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of the company. US Bancorp DE raised its stake in shares of USANA Health Sciences by 13.1% in the first quarter. US Bancorp DE now owns 4,611 shares of the company’s stock worth $124,000 after purchasing an additional 535 shares during the last quarter. PNC Financial Services Group Inc. raised its stake in shares of USANA Health Sciences by 339.6% in the first quarter. PNC Financial Services Group Inc. now owns 998 shares of the company’s stock worth $27,000 after purchasing an additional 771 shares during the last quarter. Martingale Asset Management L P raised its stake in shares of USANA Health Sciences by 5.4% in the first quarter. Martingale Asset Management L P now owns 17,542 shares of the company’s stock worth $473,000 after purchasing an additional 900 shares during the last quarter. CWM LLC raised its stake in shares of USANA Health Sciences by 109.7% in the second quarter. CWM LLC now owns 2,762 shares of the company’s stock worth $84,000 after purchasing an additional 1,445 shares during the last quarter. Finally, Principal Financial Group Inc. grew its holdings in USANA Health Sciences by 2.7% during the first quarter. Principal Financial Group Inc. now owns 55,076 shares of the company’s stock worth $1,485,000 after acquiring an additional 1,473 shares during the period. 54.25% of the stock is currently owned by hedge funds and other institutional investors.

USANA Health Sciences Trading Down 3.0%

Shares of USNA opened at $20.17 on Tuesday. USANA Health Sciences, Inc. has a 12 month low of $18.69 and a 12 month high of $41.83. The stock’s 50 day moving average is $27.66 and its two-hundred day moving average is $28.92. The firm has a market cap of $368.43 million, a P/E ratio of 22.92, a PEG ratio of 1.00 and a beta of 0.61.

USANA Health Sciences (NYSE:USNA) last issued its quarterly earnings data on Thursday, October 9th. The company reported $0.56 EPS for the quarter. USANA Health Sciences had a return on equity of 6.96% and a net margin of 1.86%.The company had revenue of $200.22 million for the quarter. USANA Health Sciences has set its Q3 2025 guidance at -0.150–0.150 EPS. Equities research analysts forecast that USANA Health Sciences, Inc. will post 2.45 EPS for the current year.

Analysts Set New Price Targets

Several analysts recently commented on the company. Zacks Research lowered USANA Health Sciences from a “hold” rating to a “strong sell” rating in a report on Tuesday, October 21st. Wall Street Zen lowered USANA Health Sciences from a “buy” rating to a “hold” rating in a report on Saturday, October 11th. Finally, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of USANA Health Sciences in a report on Wednesday, October 8th. Two analysts have rated the stock with a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, USANA Health Sciences presently has a consensus rating of “Reduce” and a consensus price target of $36.00.

Insider Buying and Selling

In other news, Director Gilbert A. Fuller sold 1,058 shares of USANA Health Sciences stock in a transaction that occurred on Thursday, August 7th. The stock was sold at an average price of $29.10, for a total value of $30,787.80. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider David Mulham Mulham sold 3,515 shares of USANA Health Sciences stock in a transaction that occurred on Wednesday, July 30th. The stock was sold at an average price of $30.26, for a total value of $106,363.90. Following the completion of the sale, the insider directly owned 9,260 shares in the company, valued at $280,207.60. This represents a 27.51% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.63% of the company’s stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.